Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded lower, with the Nasdaq Composite dropping more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session.
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero Therapeutics shares rose 7.3% to $2.37 on Friday.
Morgan Stanley To Rally Over 10%? Here Are 5 Other Price Target Changes For Wednesday
Credit Suisse raised the price target on Morgan Stanley (NYSE: MS) from $95 to $97. Credit Suisse analyst Susan Roth Katzke maintained the stock with an Outperform rating. Morgan Stanley shares rose 1.2% to $88.20 in pre-market trading.
BTIG Maintains Buy on Omnicell, Lowers Price Target to $160
BTIG analyst David Larsen maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $175 to $160.
Piper Sandler Maintains Overweight on Omnicell, Lowers Price Target to $145
Piper Sandler analyst Jessica Tassan maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $150 to $145.
Keybanc Initiates Coverage On Omnicell with Overweight Rating, Announces Price Target of $130
Keybanc analyst Scott Schoenhaus initiates coverage on Omnicell (NASDAQ:OMCL) with a Overweight rating and announces Price Target of $130.